NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,600
-9.5%
2700.0%0.00%
Q2 2023$2,873
-96.2%
270
-96.3%
0.00%
Q1 2023$76,480
+2186.4%
7,270
+2592.6%
0.00%
Q4 2022$3,345
+11.5%
2700.0%0.00%
Q3 2022$3,0000.0%2700.0%0.00%
Q2 2022$3,000
-81.2%
270
-78.7%
0.00%
Q1 2022$16,000
+6.7%
1,2700.0%0.00%
Q4 2021$15,000
-11.8%
1,2700.0%0.00%
Q3 2021$17,000
+6.2%
1,2700.0%0.00%
Q2 2021$16,000
+14.3%
1,2700.0%0.00%
Q1 2021$14,0000.0%1,2700.0%0.00%
Q4 2020$14,000
+27.3%
1,2700.0%0.00%
Q3 2020$11,000
-15.4%
1,2700.0%0.00%
Q2 2020$13,000
-7.1%
1,270
-7.0%
0.00%
Q1 2020$14,000
-22.2%
1,3650.0%0.00%
Q4 2019$18,000
+63.6%
1,365
+7.5%
0.00%
Q3 2019$11,000
-21.4%
1,2700.0%0.00%
Q2 2019$14,000
-22.2%
1,270
-3.2%
0.00%
Q1 2019$18,000
+500.0%
1,312
+320.5%
0.00%
Q4 2018$3,000
-40.0%
312
+15.6%
0.00%
Q3 2018$5,0000.0%2700.0%0.00%
Q2 2018$5,000
+25.0%
2700.0%0.00%
Q1 2018$4,0000.0%2700.0%0.00%
Q4 2017$4,0000.0%2700.0%0.00%
Q3 2017$4,000
+33.3%
270
+59.8%
0.00%
Q4 2016$3,000
+50.0%
169
+14.2%
0.00%
Q2 2016$2,0000.0%1480.0%0.00%
Q1 2016$2,0001480.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders